Biopharmaceutics and Pharmacokinetics Considerations Advances in Pharmaceutical Product Development and Research Series
2. Biopharmaceutics and Pharmacokinetics considerations in drug research
3. Bioavailability and bioequivalence research in Product Development
4. Pharmacokinetic characterization of drugs and new product designing
5. Pharmacokinetic Modulation with Particulate Drug Formulations
6. Dose, Dosage regimen and Dose adjustment
7. Implications of Bio-Nanotechnology in neuroscience, tissue engineering and cancer therapy
8. Physiologic pharmacokinetics models: Application and limitations
9. Chronopharmacokinetics in drug design
10. Drug toxicity and forensic pharmacokinetics
11. Recent advancements in Pharmacogenomics
12. Biocompatibility testing of biomaterials and biologicals
13. Metabolic kinetics
14. Animal handling and ethical considerations
15. Biopharmaceutic and pharmacokinetic aspects of controlled release systems
16. Degradation of biomaterials in biological environment
17. Safety and long-term toxicity evaluation of polymers used in Pharmaceutical Product Development: Regulatory considerations
18. Toxicity and toxicokinetic consideration in product development and drug research
19. Environmental and safety aspects of bio-nanotechnology
20. Toxicity considerations on repetitive accumulation of polymeric materials
Researchers in pharmacokinetics and scientists who work on animals from both academia and industry as well s researchers and advanced students in Pharmaceutical Sciences, Bioengineering, Pharmacology, Drug Development and Chemistry.
- Examines the most recent developments in biopharmaceutics and pharmacokinetics for pharmaceutical sciences
- Covers the principles, methodologies and technologies of biopharmaceutics and pharmacokinetics
- Focuses on the pharmaceutical sciences, but also encompasses aspects of toxicology, neuroscience, environmental sciences and nanotechnology
Date de parution : 07-2021
Ouvrage de 752 p.
19x23.4 cm
Thèmes de Biopharmaceutics and Pharmacokinetics Considerations :
Mots-clés :
drug research; product development; toxicokinetic; ethics; nanotechnology; dosage; bioavailability; animal testing